A hybrid 4-item Krousel-Wood Medication Adherence Scale predicts cardiovascular events in older hypertensive adults.

Journal of Hypertension
Marie Krousel-WoodPaul Muntner

Abstract

There is a need for a brief, open access, self-report medication adherence scale that overcomes challenges of existing adherence tools, is associated with incident cardiovascular disease (CVD), and identifies low 'implementation' adherers to antihypertensive medications to facilitate blood pressure management. Antihypertensive medication adherence was assessed in a cohort of 1532 older hypertensive adults without prior CVD using the self-report 4-item Krousel-Wood Medication Adherence Scale (K-Wood-MAS-4), a hybrid tool developed to predict pharmacy refill and which captures four domains of adherence behavior: self-efficacy, physical function, intentional medication-taking, and forgetfulness. The 4-item scale categorized participants as low and high adherers using scores at least 1 and less than 1, respectively. Participants were followed after K-Wood-MAS-4 assessment to identify incident CVD events (stroke, myocardial infarction, congestive heart failure, or CVD death). The prevalence of low adherence was 38.7%. During a median follow-up of 2.8 years (maximum 3.8 years), 136 (8.9%) participants had an incident CVD event; 12.8 and 6.4% in low and high adherers, respectively. The adjusted hazard ratio (aHR) for incident CVD asso...Continue Reading

References

Jun 1, 1992·Journal of Clinical Epidemiology·R A DeyoM A Ciol
Jan 1, 1991·Social Science & Medicine·C D Sherbourne, A L Stewart
Aug 22, 2000·Progress in Cardiovascular Nursing·M T KimD M Levine
Oct 25, 2002·American Journal of Epidemiology·Diane E BildRussell P Tracy
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jul 23, 2003·Journal of Clinical Epidemiology·Gbenga OgedegbeMary E Charlson
May 24, 2005·Medical Care·Michael C SokolRobert S Epstein
May 6, 2008·The Journal of Clinical Hypertension·Donald E MoriskyHarry J Ward
Nov 29, 2008·Stroke; a Journal of Cerebral Circulation·Fatima-Zohra KettaniSylvie Perreault
Feb 19, 2010·Journal of General Internal Medicine·James E BaileyWilliam C Cushman
Dec 16, 2010·Journal of Hypertension·Giovanni CorraoGiuseppe Mancia
Sep 22, 2011·ClinicoEconomics and Outcomes Research : CEOR·Luca Degli EspostiEzio Degli Esposti
Apr 11, 2012·British Journal of Clinical Pharmacology·Bernard VrijensUNKNOWN ABC Project Team
Oct 17, 2012·Annals of Internal Medicine·John F Steiner
Apr 13, 2013·Clinical Medicine & Research·Sharon J RolnickRichard J Bruzek
Nov 6, 2013·Prevention Science : the Official Journal of the Society for Prevention Research·Derek S BrownJohn P Barile
Jul 1, 2014·The American Journal of the Medical Sciences·Marie Krousel-WoodLisa L Lahey
Nov 26, 2016·The Medical Clinics of North America·Erin Peacock, Marie Krousel-Wood

❮ Previous
Next ❯

Citations

Oct 4, 2019·Translational Behavioral Medicine·Ian M KronishCorrine I Voils
Mar 1, 2019·Journal of Hypertension·Naga Venkata K Pothineni, Jawahar L Mehta
Oct 17, 2020·International Journal of Hypertension·Nasser Ibrahim Abu-El-NoorMysoon Khalil Abu-El-Noor
Mar 12, 2021·American Journal of Hypertension·Marie Krousel-WoodRichard Petty

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.